leadership
confidence high
sentiment positive
materiality 0.40
Biostage appoints Ron Packard, CEO of Pansophic Learning, to Board of Directors
Harvard Apparatus Regenerative Technology, Inc.
- Ron Packard appointed as Class II director effective April 5, 2023; term until 2024 annual meeting.
- Receives stock options valued at $25,000 vesting quarterly over one year; also standard non-employee director compensation ($20,000 cash + $25,000 annual option grant).
- Packard is CEO/Founder of Pansophic Learning, former CEO/Founder of K12 Inc., which he grew to ~$1B revenue and led through NYSE IPO.
- Previous roles include McKinsey & Company (biotech/semiconductors), Goldman Sachs (M&A), and holds CFA designation.